Green Biology successfully listed on the GEM board of the Shenzhen Stock Exchange on September 2, 2026. As a upstream supplier to global fragrance giants, the company’s core advantage lies in its industrial production technology for high-value molecules such as turquoise ketone, and its deep partnership and joint research with international giant Cori with a history of over twenty years. The funds raised through this listing are mainly used for the expansion of its production capacity to 6,300 tons of high-quality fragrances per year, aiming to capitalize on the trend of global supply chains shifting to the Asia-Pacific region and fill the industry’s supply gap. With its leading registration capabilities in compliance certifications such as REACH and its gold rating from EcoVadis (ranked among the top 3 globally), Green Biology has built a unique ESG and supply chain trust advantage, transitioning from a “leading player in China” to a “global core supplier”.
Green Bio listed on the GEM board of the Shenzhen Stock Exchange on September 2, 2026. As a upstream supplier to global fragrance giants, the company provides chemical base products that determine fragrance properties. Its core advantage lies in its industrial production technology for high-difficulty molecules such as turquoise ketone, and its deep partnership and joint research with international giants like IFF over a period of twenty years. The funds raised through this listing are aimed at expanding its production capacity to 6,300 tons of high-quality fragrances per year, aiming to benefit from the global supply chain shift to the Asia-Pacific region and fill the industry’s supply gap. With its leading registration capabilities for compliance certifications such as REACH and its gold rating from EcoVadis (ranked among the top 3 globally), Green Bio has built a unique ESG and supply chain trust advantage, transitioning from a “leading player in China’s niche market” to a “global core supplier.”